아베마르는 헝가리에서 개발된 항암 면역의 대명사 입니다..
체중 70kg 이하는 하루 1포를 아침 식사 1시간전 물에 타서 마십니다.
70kg 이상은 하루 두 포를 권해 드립니다.
드실때는 비타민제와 함께 드시지 마십시요. 아베마르를 드시기 두 시간 내외로는
비타민제의 섭취를 삼가하여 주십시요.
아베마르는 면역치료의 선구자적인 역할을 수행하고 있는 세계적인 항암식품 입니다.
Avemar® is recommended for patients suffering from malignant tumors as a supplement to clinical oncology treatment (surgery, radiotherapy, chemotherapy, immunotherapy, ... etc). Avemar supports other cancer treatments. Avemar is used to treat malignant tumors, immune system disorders and autoimmune diseases. Avemar may assist in the treatment of many cancers including breast, lung, prostate, colon, cervical cancer, melanoma, leukaemia.
Avemar aids, assists or helps in the maintenance or improvement of general well-being. May assist in improving the immune function. Helps boost the immune system. Acts as an antioxidant, has antioxidative effect. Free radical quencher.
Avemar aids, assists or helps in the maintenance or improvement of general well-being. May assist in improving the immune function. Helps boost the immune system. Acts as an antioxidant, has antioxidative effect. Free radical quencher.
The recommended serving is 1 sachet (17g) daily prepared as instructed, if possible, approximately 1 hour before a meal.
:: Buy Avemar now!
Avemar is delivered in a special temperature controlled package direct to your door. We will deliver your purchase to you in 3-6 working days by EMS /Fast/ International Courier!
Avemar® Product Research
The AVEMAR Research Program has been funded by many government organizations such as:The Ministry of Education, Biotechnology and OTKA [Scientific Research Foundation] in
The Ministry of Health and the Ministry of Science and Technology in
The Scientific Program, NATO.
More than 100 published papers review the clinical and experimental results obtained with this extract and have been published in prestigious journals.
There are currently 20 peer-reviewed studies accessible on Pub Med [US National Library of Medicine].
In vitro studies of cell cultures, animal studies and clinical trials with over 1200 people to date, have been undertaken in Hungary, Israel, Spain, Italy, Russia and the US to name a few.
